
Same old Peloton, new macro headache
UBS is still in Peloton’s corner, sticking with a Buy rating on the stock. That matters because Peloton has been trying to prove it can be more than a pandemic-era workout fad, and analyst support can help keep the “maybe this turnaround is real” narrative alive.
Tariffs: the gym membership nobody asked for
The wrinkle here is tariffs. When trade policy shifts, hardware-heavy companies can feel it fast, and Peloton still lives in a world of bikes, tread, and supply-chain math. If costs rise, the company has to either eat them, pass them on, or find a way to magically make margins do more yoga.
The other not-so-great number
The article also flags $4.1 million in insider selling over the past three months, with no insider buying. That doesn’t automatically mean doom, but it’s the kind of thing investors notice when they’re already squinting at a turnaround story.
What this means for you
A Buy rating is nice, but it’s not a free pass. For Peloton, the real question is whether demand, pricing, and costs can all behave at once — which, as anyone who’s ever tried to stay on a workout plan knows, is easier said than done.
Big picture: Peloton’s still trying to turn from meme-stock gym equipment into a durable business, and every tariff twist makes that path a little bumpier.
